Journal
JOURNAL OF MOLECULAR DIAGNOSTICS
Volume 8, Issue 2, Pages 209-217Publisher
ELSEVIER SCIENCE INC
DOI: 10.2353/jmoldx.2006.050135
Keywords
-
Categories
Funding
- NCI NIH HHS [P01 CA087969, R01 CA075090, P01 CA55075-13, P01 CA87969-03, P01 CA055075] Funding Source: Medline
Ask authors/readers for more resources
Assays to measure DNA methylation, which are important in epigenetic research and clinical diagnostics, typically rely on conversion of unmethylated. cytosine to uracil by sodium bisulfite. However, no study has comprehensively evaluated the precision and performance characteristics of sodium bisulfite conversion and subsequent quantitative methylation assay. We developed quantitative real-time polymerase chain reaction (MethyLight) to measure percentage of methylated reference (PMR, ie, degree of methylation) for the MGMT, MLH1, and CDKN2A (p16) promoters. To measure the precision of bisulfite conversion, we bisulfite-treated seven different aliquots of DNA from each of four paraffin-embedded colon cancer samples. To assess run-to-run variation, we repeated MethyLight five times. Bisulfite-to-bisulfite coefficient of variation (CV) of PMR ranged from 0.10 to 0.38 (mean, 0.21), and run-to-run CV of PMR ranged from 0.046 to 0.60 (mean, 0.31). Interclass correlation coefficients were 0.74 to 0.84 for the three loci, indicating good reproducibility. DNA mixing study with methylated and unmethylated. DNA showed good linearity of the assay. Of 272 colorectal cancers evaluated, most showed PMR either < 1 or > 10, and promoter methylation (PMR > 4) was tightly associated with loss of respective protein expression (P < 10(-16)). In conclusion, sodium bisulfite conversion and quantitative MethyLight assays have good precision and linearity and can be effectively used for high-throughput DNA methylation analysis on paraffin-embedded tissue.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available